ABSTRACT. Data integration has become a useful strategy for uncovering new insights into complex biological networks. We studied whether this approach can help to delineate the signal transducer and activator of transcription 6 (STAT6)-mediated transcriptional network driving T helper (Th) 2 cell fate decisions. To this end, we performed an integrative analysis of publicly available RNA-seq data of Stat6-knockout mouse studies together with STAT6 ChIP-seq data and our own gene expression time series data during Th2 cell differentiation. We focused on transcription factors (TFs), cytokines, and cytokine receptors and delineated 59 positively and 41 negatively STAT6-regulated genes, which were used to construct a transcriptional network around STAT6. The network illustrates that important and well-known TFs for Th2 cell differentiation are positively regulated by STAT6 and act either as activators for Th2 cells (e.g., Gata3, Atf3, Satb1, Nfil3, Maf, and Pparg) or as suppressors for other Th cell subpopulations such as Th1 (e.g., Ar), Th17 (e.g., Etv6), or iTreg (e.g., Stat3 and Hif1a) cells. Moreover, our approach reveals 11 TFs (e.g., Atf5, Creb3l2, and Asb2) with unknown functions in Th cell differentiation. This fact together with the observed enrichment of asthma risk genes among those regulated by STAT6 underlines the potential value of the data integration strategy used here. Thus, our results clearly support the opinion that data integration is a useful tool to delineate complex physiological processes.
ABSTRACT. Data integration has become a useful strategy for uncovering new insights into complex biological networks. We studied whether this approach can help to delineate the signal transducer and activator of transcription 6 (STAT6)-mediated transcriptional network driving T helper (Th) 2 cell fate decisions. To this end, we performed an integrative analysis of publicly available RNA-seq data of Stat6-knockout mouse studies together with STAT6 ChIP-seq data and our own gene expression time series data during Th2 cell differentiation. We focused on transcription factors (TFs), cytokines, and cytokine receptors and delineated 59 positively and 41 negatively STAT6-regulated genes,
INTRODUCTION
The development of microarray technologies and next-generation sequencing (NGS) methods in the last decades has transformed modern biology (Schuster, 2008) . Thousands of high-throughput studies with manifold research foci have resulted in an explosion of heterogeneous omics data. Public online databases such as GEO for microarray and NGS data (Edgar et al., 2002) , TRANSFAC for transcription factors (TFs) and their DNA binding sites (Wingender et al., 1996) , or tranSMART for clinical and translational research (Athey et al., 2013 ) ensure long-term access. The availability of these omics data encourages their reuse-even in another context. However, these data are derived from different technological platforms, have distinct formats, and come from diverse sources, which challenge their uniform processing and integrated analysis. To this end, comprehensive data integration approaches are urgently needed.
Data integration strives for the usage of multiple omics datasets from distinct methods such as gene expression analysis through microarray or RNA-seq, ChIP-seq, mass spectrometry, genome-wide single-nucleotide polymorphism (SNP) genotyping, and GWAS. Moreover, data integration allows use of data of the same type but from various sources with multiple formats. Several reviews and general comments have predicted that the integration of omics data and clinical data would facilitate identification of novel biomarkers of diseases and candidate targets for therapeutic approaches. All these could help to increase the efficiency of drug discovery (Searls, 2005; Slater et al., 2008; Bielekova et al., 2014; Subramanian et al., 2015) .
Consequently, data integration has been applied extensively in biomedical research over the previous decades, e.g., to study the functional and structural relationships of genes for comprehensive network analysis. Recently, Subramanian et al. (2015) summarized the potential of data integration and network analysis for uncovering physiological processes of immune cells. For instance, in macrophages, gene expression dynamics and scanning for TF-binding sequence motifs have been used to elucidate transcriptional networks on a large scale (Ramsey et al., 2008; Litvak et al., 2012) , while a combination of genome-wide mRNA expression data and network perturbation using methods such as RNAi knockdown was applied to identify useful intervention strategies in infections (König et al., 2010) . In T helper (Th) cells, Ciofani et al. (2012) demonstrated the power of data integration to construct a regulatory network for Th17 cell differentiation: they applied an integrative approach to delineate the Th17 cell global transcriptional regulatory network using meta-analysis of genome occupancy of multiple TFs, RNA-seq data of TF-deficient T cells, and immune cell transcriptome data. With this approach, they identified the TFs BATF and IRF4 as key activators and FOSL2 as a modulator of Th17 cell differentiation.
In this work, we used data integration as a tool for understanding the Th cell fate decisions of naïve Th cells during differentiation, specifically focusing on Th2 cells. The differentiation of naïve CD4 + T cells into Th cell subtypes, such as Th2, Th1, Th17, and induced T regulatory (iTreg) cells, is regulated by specific cytokine milieus and complex TF networks. The cytokine interleukin 4 (IL4) activates signal transducer and activator of transcription 6 (STAT6) and initiates the differentiation of Th2 cells. Th2 cells themselves secrete the signature cytokines IL4, IL5, and IL13 and express the master TF GATA3 (Yamane and Paul, 2013) . However, cooperation among TFs to determine the specific program for Th2 cell differentiation is poorly understood. Nevertheless, it is of high medical importance because Th2 cells play a critical role in the pathogenesis of allergies and asthma (Del Prete, 1992; Kay, 2001) .
To identify critical TFs and cytokines for Th2 cell differentiation, we used an integrative strategy combining global gene expression and DNA-binding data for Th2 cells from wild-type (WT) and Stat6-knockout (KO) mice and constructed a global gene regulatory network for Th2 cells around the TF STAT6. We discovered that TFs, which are important for Th2 cell differentiation, are positively regulated by STAT6 and act either as activators for Th2 cells or as suppressors for Th1, Th17, or iTreg cells. Additionally, we observed a Th2-cell subtype-specific expression preference of the STAT6-positively regulated TFs and an enrichment of asthma risk genes within STAT6-regulated genes. Finally, we identified 11 STAT6-regulated and -bound TFs with unknown functions in Th cell differentiation. Further experiments are needed to examine whether these TFs are indeed crucial for Th2 cell differentiation and to assess their potential for therapeutic manipulations. The comprehensive strategy used here illustrates the power of integrating global gene and DNA binding data for construction of transcriptional networks in Th2 cell differentiation and supports the opinion that data integration is a useful tool to identify novel biological mechanisms.
RESULTS AND DISCUSSION

Construction of a network of STAT6-regulated genes in Th2 cells
To comprehensively identify TFs acting as regulatory hubs in Th2 cell differentiation, we performed an integrated analysis of four publicly available global gene expression and DNA-binding datasets for Th2 cells and one in-house generated gene expression dataset ( Figure 1A ). The datasets are displayed in Figure 1 : RNA-seq data for Stat6-KO mice, microarray data for Th cells, STAT6 ChIP-seq data, and RNA-seq gene expression time series for Th cells. The applied integration strategy enabled derivation of a gene regulatory network around the TF STAT6, which fundamentally influences the cell fate decision towards the Th2 cell subtype (Yamane and Paul, 2013) .
First, we identified STAT6-regulated genes by analyzing RNA-seq data for 7-day-old in vitro differentiated Th2 cells of WT and Stat6-KO mice (Figure 1, green) (Vahedi et al., 2012) , which yielded 1047 differentially expressed genes. These presumed STAT6-regulated genes were filtered for TFs, cytokines, and cytokine receptors based on a published Th cell microarray dataset (Figure 1 , purple) of 782 TFs and 271 cytokines and cytokine receptors in the context of induction, differentiation, and maintenance of Th cell subsets (Wei et al., 2009) . The resulting 100 genes ( Figure 1B) formed the basis of the STAT6 network derived in the subsequent steps. These 100 genes were compared to STAT6 ChIP-seq data for 7-day-old Th2 cells (Figure 1, orange) (Wei et al., 2010) to discriminate between direct and indirect targets of STAT6 ( Figure 1B) . Finally, we integrated expression time series of Th2 cells (Hu et al., 2013 ) (in-house generated RNA-seq expression data of Th2 cells, manuscript in preparation: Jargosch M., Hoang Y., Kröger S., Fang Z., Chen W., Baumgrass R.) to characterize these candidates with respect to their expression behavior compared to naïve CD4 + T cells in the early (0-48 h) and late (72-336 h) stages of Th2 cell differentiation. The resulting STAT6 network shown in Figure 2 contains the following information: i) how STAT6 influences the expression of other genes, ii) whether genes encode TFs or cytokines/cytokine receptors, iii) whether gene regions are directly bound by STAT6, and iv) whether genes are differentially expressed in early and/or late differentiation of Th2 cells compared to naïve CD4 + T cells. The network in Figure 2 depicts the genes in a four-ring structure around STAT6 based on their expression behavior during the early and late stages of Th2 cell differentiation.
The gene regulatory network includes 100 TFs, cytokines, and cytokine receptors in Th2 cells that are regulated by (48 genes) or even bound by STAT6 (52 genes) ( Figure  2 ). Altogether, 59 and 41 genes are up-and down-regulated by STAT6, respectively. The integration of expression time series of Th2 cells revealed that 98 of these 100 genes are also differentially expressed in polarized Th2 cells compared to naïve CD4 + T cells, with most differentially expressed in both the early and late phases of differentiation. The expression of 52 and 26 genes is increased and decreased in Th2 cells, respectively, where 20 genes show opposite expression in the early and late phases. Gene regulatory network of STAT6-regulated genes in Th2 cells. The network is focused on TFs (squares) and cytokines or cytokine receptors (ovals) and shows indirect (48 genes) and direct targets (52 genes) of STAT6. The edge color indicates the effect of STAT6 on gene expression (blue = down-regulated, yellow = upregulated). Arrowheads indicate direct binding by STAT6. The node color (blue = differentially decreased, yellow = differentially increased, white/grey = not differentially expressed) characterizes the expression of these genes in Th2 cells compared to naïve CD4 + T cells (inside color = early phase, outline color = late phase). The network layout is based on four rings around STAT6 in graded grey tones. Rings from inside to outside contain genes according to their differential expression behavior in the early (1), early and late (2), or late (3) phases or lack of differential expression (4) in Th2 cells compared to naïve cells.
The network contains important genes known to be active in Th2 cells, such as the master TF of Th2 cells, Gata3; the Th2 cell-specific surface receptors Ccr3, Ccr4, and Ccr8; and the cytokines Il4 and Il6, which are positively regulated by STAT6 D'Ambrosio et al., 1998; Yamane and Paul, 2013) . Importantly, master TFs for other Th cell subsets are included but negatively regulated by STAT6, such as Foxp3 in iTreg cells, Tbx21 in Th1 cells, and Rorg in Th17 cells (Yamane and Paul, 2013) .
Th2 cell-specific TFs are positively regulated by STAT6 and increased in Th2 cells
It is well accepted that networks of multiple TFs are required to execute a full differentiation program and that many of them act as activators or repressors in a contextdependent manner (Novershtern et al., 2011) . Next, we studied the function of STAT6-regulated and STAT6-bound genes encoding TFs in Th cell differentiation processes and identified Th2 cell-specific TFs as activators for Th2 differentiation or repressors for Th1, Th17, or iTreg cell differentiation. We filtered the 100 STAT6-regulated genes for TFs and performed a literature search regarding their function in differentiation processes. Their main functions in Th cell differentiation and their regulation by STAT6 in Th2 cells are summarized in Table 1 . The 32 TFs were divided into three groups: i) associated with differentiation of Th2 cells, ii) associated with differentiation of other Th cell subtypes, and iii) previously unknown association with differentiation of Th cells. Most Th2 cell-specific TFs were up-regulated by STAT6. Consistently, the majority of STAT6-negatively regulated TFs were activators for Th1, Th17, or iTreg cell differentiation. Interestingly, there were only two TFs acting as repressors of Th2 cell differentiation within the STAT6-negatively regulated TFs (Nfatc3 and Irf1). Thus, STAT6-driven differentiation of Th2 cells is mainly modulated by activators and not preferentially by repressors.
The 32 STAT6-regulated TFs were included into a literature search concerning the context of T cell differentiation within the publication period 2000-2015. Depending on the discovered function in differentiation processes the TFs were divided into three groups: i) associated with differentiation of Th2 cells, ii) associated with differentiation of other Th cell subtypes and iii) not associated with differentiation of Th cells. The list was supplemented with the information how the gene expression of each TF is regulated by STAT6 and how their differential expression pattern is directed in early and late polarized Th2 cells compared to naïve T cells (↑ = increased (yellow), ↓ = decreased (blue) and n.diff = not differentially expressed).
Six TFs were associated with the differentiation of Th2 cells: Gata3, Atf3, Satb1, Nfil3, Maf, and Pparg; these TFs were positively regulated by STAT6 and increased in Th2 cells. The expression of Gata3, Satb1, Nfil3, Maf, and Pparg was previously shown to be increased by STAT6 in primary human CD4 + T cells by blocking STAT6 with RNAi . Additionally, IL4 is known to increase the expression of Atf3 and Satb1 (Chen et al., 2003b; Ahlfors et al., 2010) . Furthermore, SATB1 coordinates Th2 cell differentiation by positively regulating Gata3 (Notani et al., 2010) . SATB1, NFIL3, MAF, and PPARG positively regulate the gene expression of the Th2 cytokine Il4 (Ribeiro de Almeida et al., 2009; Kashiwada et al., 2011; Lai et al., 2012; da Rocha Junior et al., 2013; Kwon et al., 2014) . In addition to the positive effects on Th2 cell differentiation, NFIL3 suppresses Th17 cell development by directly binding and repressing the Rorg promoter . PPARG is also known to suppress Th17 and Th1 cell differentiation by decreasing the level of IFNγ production in splenocytes (da Rocha Junior et al., 2013 (Wuelling et al., 2009) Fifteen TFs were associated with the differentiation of other Th cell subtypes without a reported main function in Th2 cell differentiation. Of these, eight (Ah, Stat3, Etv6, Hif1α, Irf7, Stat2, Batf, and Crem) were increased, and seven (Irf1, Irf8, Nfatc3, Pou2af1, Rora, Klf2, and Tcf7) were decreased by STAT6. In summary, STAT6-negatively regulated TFs were positive regulators for other Th cell populations using different modes of action. The TFs IRF8, IRF1, and NFATC3 enhance Th1 cell differentiation by modulating the function of APCs (Taki et al., 1997; Salkowski et al., 1999; Maruyama et al., 2003; Lohoff and Mak, 2005; Zhang et al., 2012) or directly promoting the expression of Th1 cytokines Ifng and Tnf (Chen et al., 2003a) . The TFs POU2AF1 and RORα promote Th17 cell differentiation (Yi et al., 2012; Yosef et al., 2013) , and KLF2 is necessary for the generation of iTreg cells (Pabbisetty et al., 2014) . Additionally, IRF1 and NFATC3 are known as suppressors for Th2 cytokines (Elser et al., 2002; Rengarajan et al., 2002; Chen et al., 2003a) . Consistent with this, a few TFs were increased by STAT6 and associated with suppressive processes in Th1, Th17, or iTreg cells. For instance, AR inhibits IL12 signaling and Th1 cell differentiation by up-regulating Ptpn1 (Kissick et al., 2014) , STAT3 activation and HIF1α inhibit iTreg cell differentiation (Laurence et al., 2012; Palazon et al., 2014) , and ETV6 is known as a repressor in Th17 cells (Ciofani et al., 2012) . However, STAT3 can also induce Th17 cell differentiation (Zhu and Paul, 2010 ) and promote Th2 cell differentiation together with IL6 (Stritesky et al., 2011) .
Another 11 TFs were previously unreported in the context of Th cell differentiation. However, often they are associated with the differentiation processes of other cell subtypes such as B cells, dendritic cells, chondrocytes, and adipocytes (vide infra).
In summary, our analyses of the literature confirm the value and highlight the explanatory power of the STAT6 network. Furthermore, they confirm that important TFs for Th2 cell differentiation are up-regulated in the STAT6 network and acting either as activators for Th2 cells or suppressors for Th1, Th17, or iTreg cells.
Most of the STAT6-positively regulated genes are preferentially expressed in Th2 cells
To validate the Th2 cell specificity of the STAT6 network, we next studied gene expression preferences in Th cells for the 100 STAT6-regulated genes. To evaluate the hypothesis that STAT6-positively regulated genes have higher expression in Th2 cells than STAT6-negatively regulated genes, we compared the gene expression levels for each of the 100 STAT6-regulated genes in 10-day-old in vitro differentiated Th1, Th2, Th17, and iTreg cells (Wei et al., 2009) . We identified 64 genes preferentially expressed in one Th-cellsubtype. We subdivided these genes into Th1-, Th2-, Th17-, and iTreg-specific genes and discriminated between STAT6-positively (35) and STAT6-negatively regulated (29) genes ( Figure 3A) . Most of the 35 STAT6-positively regulated genes (22) were preferentially expressed in Th2 cells. Importantly, there were no Th2 subtype-specific genes among the STAT6-negatively regulated genes, validating the Th2 cell specificity of the STAT6 network. Furthermore, these results support the observation that Th2-subtype-specific genes were upregulated by STAT6, whereas Th1-, Th17-, or iTreg-subtype-specific genes were mainly down-regulated by STAT6.
STAT6-regulated genes are associated with asthma risk genes
Hyper-activated CD4 + T cells play an important role in allergic asthma and various autoimmune diseases such as rheumatoid arthritis. Allergic asthma is associated with an infiltration of Th2 cells, whereas autoimmune diseases are driven by Th1 and Th17 cells (Dolhain et al., 1996; Kay, 2001 ). Therefore, we suspected an enrichment of asthma risk genes within the STAT6-regulated genes in Th2 cells compared to STAT4-regulated genes in Th1 cells. Indeed, the comparison of asthma risk genes (Renkonen et al., 2010) with the datasets of STAT6-regulated genes in Th2 cells and STAT4-regulated genes in Th1 cells showed an enrichment of asthma risk genes in the set of STAT6-regulated genes.
Recently, asthma risk genes were identified by genome-wide SNP association studies. A meta-analysis of SNPs by Renkonen et al. (2010) identified 125 asthma-associated genes. Filtering these risk genes for TFs, cytokines, and cytokine receptors (microarray data for Th cells, Wei et al., 2009 ) yielded 33 asthma risk genes ( Figure 3B , red), which were integrated with the 100 STAT6-regulated genes in Th2 cells ( Figure 3B , green) and the 274 STAT4-regulated genes in Th1 cells ( Figure 3B, gray) . Similar to the STAT6-regulated genes, the STAT4-regulated genes were identified by analyzing RNA-seq data for 7-day-old in vitro differentiated Th1 cells of WT and Stat4-KO mice (Vahedi et al., 2012) . The analysis revealed that 12 of the 100 STAT6-regulated genes were asthma risk genes. Of these genes seven and five were positively and negatively regulated by STAT6, respectively. Among the positively regulated asthma risk genes ( Figure 3B , yellow bars), there were Th2-subtype-specific genes such as Gata3, Ccr3, Il6, Il4, Il1rl1, and Pparg, which are also preferentially expressed in Th2 cells (microarray data of Th cells, Wei et al., 2009 ). Consistently, the negatively regulated asthma risk genes ( Figure 3B , blue bars) were the Th1-subtype-specific genes Tbx21, Ifng, Tnf, Il18r1, and Cxcr3. Unexpectedly, we also revealed 11 asthma risk genes within the STAT4-regulated genes in Th1 cells; however, almost all of these were regulated oppositely by STAT4 in Th1 cells compared to STAT6 in Th2 cells.
Our results support the common view that asthma is associated with an imbalanced Th1/Th2 cell ratio. Recently, it was demonstrated in an airway inflammation model that the frequency of Th2 cells and the absolute amounts of Th2 cytokines and actived STAT6 TF were increased. Consequently, Th1 cytokines and the activated STAT4 TF are decreased in this model (Chen et al., 2015) .
In summary, this analysis validates the Th2 cell specificity of the STAT6 network and confirms that the STAT6 network includes genes that are positively associated with the Th2 cell differentiation and up-regulated by STAT6 as well as genes that are positively associated with the differentiation of Th1, Th17, or iTreg cells and that are mostly down-regulated by STAT6.
Novel and potentially important TFs for Th2 cell fate decisions
We applied the described data integration strategy to better understand Th2 cell fate decisions and, in particular, to delineate the gene regulatory network of Th2 cells to unravel novel important TFs in Th2 cell differentiation. We identified 11 direct target genes of STAT6 with previously unreported functions in Th cell differentiation. Among these were eight (Asb2, Atf5, Creb3l2, Cebpb, Cited2, Rai14, Tanc2, and Ddit3) and three genes (Aff3, Trps1, and Pou2f2) positively and negative regulated by STAT6, respectively (Table 1) .
The TFs AFF3 and POU2F2 have not been directly associated with Th cell differentiation processes; however, they have been connected with Th1 cells. Aff3 is a rheumatoid arthritis susceptibility gene that also influences the response to anti-TNF treatment (Tan et al., 2010) . The function of POU2F2 in B cell differentiation was extensively studied and shown to mediate the physical interaction of B and T cells (Corcoran et al., 2014) ; however, its role in Th cell differentiation has not been described. In our network, the expression of Pou2f2 was increased in the early and late stages of Th2 cell differentiation compared to naïve T cells. However, Cron et al. (2001) reported that POU2F2 decreases Il4 promoter activity and increases Il2 promoter activity. Therefore, POU2F2 promotes a Th1 pattern rather than a Th2 pattern of cytokine gene expression by activated CD4 + T cells. This observation was confirmed by gene expression data from Hu et al. (2013) reporting a twofold higher expression of Pou2f2 in Th1 cells than in Th2 cells.
The eight STAT6-positively regulated and previously unidentified Th2 subtyperelated TFs (Table 1) are of particular interest for us because these TFs act as activators in Th2 differentiation or suppressors in Th1, Th17, or iTreg differentiation, as shown for the other identified genes (Table 1) . Interestingly, the TFs ATF5 and CREB3L2 are described as transcriptional activators of differentiation processes of adipocytes (Zhao et al., 2014) and chondrocytes (Imamura et al., 2014; Saito et al., 2014) , activating transcription by binding to the cAMP response element (Umemura et al., 2015) . The TF ASB2 was identified as a growth inhibitor in myeloid leukemia cells (Guibal et al., 2002) through promoting ubiquitination of Notch targets such as E2A and JAK2 (Nie et al., 2011) . In human T cells, E2A has been described as a positive regulator of Gata3 by displacement of the repressor ZEB (Grégoire and Roméo, 1999) . Interestingly, we observed that Atf5, Creb3l2, and Asb2 were differentially up-regulated in both the early and late phase of Th2 cell differentiation. Currently, we are examining whether these TFs act as regulatory hubs in Th2 cell differentiation using perturbation methods and whether they are useful for manipulation of asthma and/or allergic diseases in animal models.
Our results show that an integration of publicly available and newly collected datasets with different sources, formats, applied analysis methods, and evaluation priorities is useful for discovering new contexts within biological networks for experimental validation.
MATERIAL AND METHODS
Preparation and analysis of publicly available data for gene regulatory network reconstruction
We used selected public datasets to reconstruct gene regulatory networks, namely RNA-seq (Vahedi et al., 2012; Hu et al., 2013) , microarray (Wei et al., 2009) , and ChIPseq (Wei et al., 2010) datasets. In addition, we generated an RNA-seq data for Th2 cell differentiation. GEO accession numbers and corresponding references are listed in S1 Table. The initial network was established based on a Stat6-KO mouse RNA-seq experiment by Vahedi et al. (2012) (GSE40463) using published normalized fpkm values to identify differentially expressed genes. Differential expression was defined as an absolute log2(fold change) > 1. Low-expressed genes were removed (normalized fpkm < 1 in all groups).
We retrieved and integrated raw STAT6 ChIP-seq data for WT and STAT6-deficient Th2 cells (GSM550311, GSM550312 part of GSE22105) (Wei et al., 2010) . Reads were mapped to mouse genome (mm9) using BWA (Burrows-Wheeler Aligner) (Li and Durbin, 2009) . To detect TF binding sites, we applied CisGenome (Ji et al., 2008) peak detection software to all uniquely mapped reads. As described by Wei et al. (2010) , ChIP-seq peaks present in KO and WT cells were removed before TF binding analysis.
The RNA-seq experiment conducted by Hu et al. (2013) (GSE22081) was analyzed based on the available raw data to ensure compatibility with our in-house performed RNA-seq experiments (described below). Ensembl genome assembly mm10 was used for annotation of sequenced reads; for both datasets, the same tools were applied for mapping, annotation, and expression analysis. After retrieving raw data from the GEO repository, reads were mapped and indexed using tophat2 (Kim et al., 2013) and SAMtools . Detected reads per gene (gene counts) were calculated using HTSeq (Anders et al., 2015) , and then differential expression was detected with R package DESeq (Anders and Huber, 2010) . Thresholds for differentially expressed genes were defined by an absolute log2(fold change) ≥ 1 and P < 0.05. The resulting set of genes was used for further analysis and network construction. S2 Table  lists all gene expression measurements and corresponding log2(fold change) values used to construct the global gene regulatory STAT6 network.
Processing RNA-seq experiments for Th2 cells
For the differentiation cultures, BALB/cAnNCrl mice were obtained from Charles River Laboratories, Wilmington, Massachusetts, USA). Mice were bred under pathogen-free conditions. The animal experiment was performed according to state guidelines and approved by the local Ethics Committee LAGeSo (Landesamt für Gesundheit und Soziales) Berlin within the frame of animal experiment license T0187-01. Naïve CD4 + CD25 -CD45RB high T cells from spleen and lymph node cell suspensions were isolated by FACS using an Aria II sorter after surface staining with antibodies targeting CD4 (clone GK1.5), CD25 (clone PC61.5), and CD45RB (clone C363.16A). The culture medium used was RPMI 1649 + GlutaMAX (GIBCO Life Technologies, Carlsbad, California, USA), supplemented with 10% FCS, 100 U/mL penicillin, 100 µg/mL streptomycin, and 50 µM β-mercaptoethanol.
The purified naïve T cells were stimulated with 1 µg/mL plate-bound-αCD3 (clone 145-2C11) and 1 µg/mL plate-bound-αCD28 (clone 37.51) under Th2 cell polarized conditions [10 ng/mL recombinant IL2, 30 ng/mL recombinant IL4, 10 µg/mL αIL12 (clone C17.8), and 10 µg/mL αIFNγ (clone AN18.17.24)] for 5, 12, 24, and 48 h. The polarization of these Th2 cells was checked by intracellular staining of the master TF GATA3 for the 24-h (19% GATA3 producers) and 48-h cultures (85% GATA3 producers). After cultured cells were sorted for living cells using DAPI, mRNA was prepared using an RNeasy Plus Mini Kit (Qiagen, Hilden, Germany) with a gDNA degradation step. Finally, the RNA library was prepared from up to 3 µg RNA using a TrueSeq Stranded mRNA Kit (Illumina, San Diego, California, USA) and sequenced in an Illumina HiSeq system.
The quality of the extracted sequence reads was checked, and sequences were trimmed using a Solexa trimming tool. The trimmed sequence reads where processed as described for the data from Hu et al. (2013) (vide supra). Expression and log2(fold change) values are listed in S2 Table. Gene regulatory network assembly All preprocessed datasets were integrated in a large connectivity matrix describing the network. The initial network was established based on STAT6 and the 100 TFs, cytokines, and cytokine receptors differentially expressed in Stat6-KO RNA-seq experiments. Next, STAT6-bound genes from the ChIP-seq dataset were added.
Subsequently, the genes were connected to STAT6 based on their expression in the Th2-RNA-seq experiments and annotated based on the expression information in other Th cell subtypes (RNA-seq, microarray experiments). Figure 2 illustrates the final gene regulatory network visualized with Cytoscape visualization and integration software (http://www. cytoscape.org/).
Literature search of STAT6-regulated and STAT6-bound genes encoding TFs
A literature search in (http://www.ncbi.nlm.nih.gov/pubmed) was carried out in February 2015 with the search phrase <NAME_OF_TF> AND ("t cell" OR "differentiation") for the 32 selected STAT6-regulated and STAT6-bound genes encoding TFs. The result lists were manually scanned to create Table 1 , which describes the main function of each TF. Depending on this function, TFs were categorized in three groups: i) associated with differentiation of Th2 cells, ii) associated with differentiation of other Th cell subtypes, and iii) not associated with differentiation of Th cells.
Gene expression preferences of STAT6-regulated genes
We characterized the STAT6-regulated genes using expression levels from the published microarray dataset (Wei et al., 2009) for the 10-day-old Th cell subtypes Th2, Th1, Th17, and iTreg. Those genes among the 100 STAT6-regulated genes with differential expression in only one cell subtype were detected by calculating the log2(fold change) between the different Th cell subtypes. The threshold for differentially expressed genes was set at 1.4-fold [log2(fold change) = 0.5]. For example, a gene expressed at least 1.4-fold higher in Th2 cells than in Th1, Th17, and iTreg cells was assigned to the "Th2 > Th1 & Th2 > Th17 & Th2 > iTreg" category. Only 64 of the 100 STAT6-regulated genes were preferentially expressed in one cell subtype ( Figure 3A ). The log2(fold change) values and corresponding expression preferences are listed in S3 Table. Asthma risk genes within the STAT6-regulated genes A list of 125 asthma risk genes was extracted by meta-analysis of SNPs from Renkonen et al. (2010) and filtered for TFs, cytokines, and cytokine receptors (Wei et al., 2009 ) (S4 Table) . The overlap of the 33 asthma risk genes encoding TFs, cytokines, or cytokine receptors with the 100 STAT6-regulated genes in Th2 cells and with the 274 STAT4-regulated genes in Th1 cells (Vahedi et al., 2012 ) is shown in Figure 3B .
